SARTORIUS Financial Statements From 2010 to 2024
| SRT4 Stock | EUR 32.00 1.00 3.03% |
Check SARTORIUS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SARTORIUS's main balance sheet or income statement drivers, such as , as well as many indicators such as . SARTORIUS financial statements analysis is a perfect complement when working with SARTORIUS Valuation or Volatility modules.
SARTORIUS |
SARTORIUS AG UNSPADR Company Return On Equity Analysis
SARTORIUS's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current SARTORIUS Return On Equity | 0.34 |
Most of SARTORIUS's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SARTORIUS AG UNSPADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, SARTORIUS AG UNSPADR has a Return On Equity of 0.3386. This is 101.41% lower than that of the Healthcare sector and 105.66% lower than that of the Medical Instruments & Supplies industry. The return on equity for all Germany stocks is notably lower than that of the firm.
SARTORIUS AG UNSPADR Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining SARTORIUS's current stock value. Our valuation model uses many indicators to compare SARTORIUS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SARTORIUS competition to find correlations between indicators driving SARTORIUS's intrinsic value. More Info.SARTORIUS AG UNSPADR is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.31 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for SARTORIUS AG UNSPADR is roughly 3.19 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SARTORIUS's earnings, one of the primary drivers of an investment's value.About SARTORIUS Financial Statements
SARTORIUS stakeholders use historical fundamental indicators, such as SARTORIUS's revenue or net income, to determine how well the company is positioned to perform in the future. Although SARTORIUS investors may analyze each financial statement separately, they are all interrelated. For example, changes in SARTORIUS's assets and liabilities are reflected in the revenues and expenses on SARTORIUS's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in SARTORIUS AG UNSPADR. Please read more on our technical analysis and fundamental analysis pages.
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company was founded in 1870 and is headquartered in Gttingen, Germany. SARTORIUS operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 11981 people.
Currently Active Assets on Macroaxis
Other Information on Investing in SARTORIUS Stock
SARTORIUS financial ratios help investors to determine whether SARTORIUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SARTORIUS with respect to the benefits of owning SARTORIUS security.